KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 161 filers reported holding KARUNA THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.69 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $219,817 | -22.0% | 1,300 | 0.0% | 0.00% | -100.0% |
| Q2 2023 | $281,905 | +19.4% | 1,300 | 0.0% | 0.00% | – |
| Q1 2023 | $236,132 | -82.6% | 1,300 | -87.9% | 0.00% | -100.0% |
| Q2 2022 | $1,357,000 | -43.5% | 10,730 | -43.3% | 0.00% | -50.0% |
| Q1 2022 | $2,400,000 | -4.8% | 18,930 | -1.8% | 0.00% | 0.0% |
| Q4 2021 | $2,521,000 | +7.0% | 19,269 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $2,357,000 | +7.5% | 19,269 | +0.1% | 0.00% | 0.0% |
| Q2 2021 | $2,193,000 | -13.5% | 19,242 | -8.7% | 0.00% | 0.0% |
| Q1 2021 | $2,535,000 | -13.4% | 21,086 | -26.8% | 0.00% | -33.3% |
| Q4 2020 | $2,928,000 | +18.4% | 28,816 | -9.9% | 0.00% | 0.0% |
| Q3 2020 | $2,472,000 | -39.2% | 31,972 | -12.3% | 0.00% | -40.0% |
| Q2 2020 | $4,064,000 | +123.4% | 36,463 | +44.4% | 0.01% | +150.0% |
| Q1 2020 | $1,819,000 | – | 25,258 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Pivotal bioVenture Partners Investment Advisor LLC | 797,008 | $134,766,083 | 53.75% |
| Nan Fung Group Holdings Ltd | 225,688 | $38,161,584 | 30.90% |
| Sofinnova Investments, Inc. | 1,381,149 | $233,538,484 | 14.73% |
| First Light Asset Management, LLC | 303,137 | $51,257,435 | 4.87% |
| Altium Capital Management LP | 34,000 | $5,749,060 | 3.00% |
| DAFNA Capital Management LLC | 52,873 | $8,940,296 | 2.78% |
| Logos Global Management LP | 115,000 | $19,445,350 | 2.59% |
| GENERAL ATLANTIC, L.P. | 986,710 | $166,842,794 | 2.58% |
| MPM BioImpact LLC | 53,210 | $8,997,279 | 2.40% |
| Rock Springs Capital Management LP | 505,433 | $85,463,666 | 2.29% |